<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumours</z:e> were raised in both congenitally athymic ('<z:mp ids='MP_0003815'>nude</z:mp>') Swiss mice and in neonatally thymectomized, Ara-C-protected, whole-body irradiated CBA mice by subcutaneous inoculation of cells from a variety of cultured human lines </plain></SENT>
<SENT sid="1" pm="."><plain>In both types of animal, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> tended to grow massively at the site of inoculation, with some infiltration of adjacent tissues but only rarely with evidence of metastatic spread </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumours</z:e> derived from Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) lines or from EB virus-transformed lymphoblastoid cell lines (LCL) were <z:hpo ids='HP_0000001'>all</z:hpo> classified as high grade malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with a limited range of appearances on conventional histological examination </plain></SENT>
<SENT sid="3" pm="."><plain>In the material studied there were no consistent features distinguishing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-derived from LCL-derived <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Cell lines originating from other haematopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> tended to produce <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> interpreted as <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> though there were distinctive characteristics in some cases, such as highly convoluted or pleomorphic nuclei in the cells of some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> derived from T-cell <z:mpath ids='MPATH_336'>leukaemia</z:mpath> lines and plasmacytoid differentiation in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> originating from <z:mp ids='MP_0009440'>myeloma</z:mp> lines </plain></SENT>
<SENT sid="5" pm="."><plain>Malignant cell lines of epithelial origin gave rise to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with the histological appearances of anaplastic <z:mp ids='MP_0002038'>carcinomas</z:mp> readily distinguishable from the high grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> produced by haematopoietic cells </plain></SENT>
</text></document>